richard lipton, md, director, montefiore headache center; edwin s. lowe professor and vice chairman of neurology, albert einstein college of medicine..

40 under 40 - bbj class of 2018.

.

.

eptinezumab is in phase iii trials. its maker plans to submit an application with the fda later this year. it is for chronic migraine prevention..
the software identified and measured a marker of svd and then gave a score indicating how severe the disease was ranging from mild to severe..

air pollution in the united kingdom has been illegally high since 2010, leading to the premature deaths of 23,500 people each year,.

family slam health trust after pensioner's 'undignified' death.

two days later, he attended his wife's memorial service at green hills baptist church in la habra.